These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 31398495

  • 1. Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
    Papoutsaki V, Galani I, Papadimitriou E, Karantani I, Karaiskos I, Giamarellou H.
    J Glob Antimicrob Resist; 2020 Mar; 20():98-104. PubMed ID: 31398495
    [Abstract] [Full Text] [Related]

  • 2. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae.
    Ojdana D, Gutowska A, Sacha P, Majewski P, Wieczorek P, Tryniszewska E.
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of 3 Etest(®) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species.
    Pankey GA, Ashcraft DS, Dornelles A.
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):220-6. PubMed ID: 23993213
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A, Scorzolini L, Cipolla A, Mascellino MT, Cancelli F, Castaldi D, D'Abramo A, D'Agostino C, Russo G, Ciardi MR, Mastroianni CM, Vullo V.
    J Antimicrob Chemother; 2017 Jul 01; 72(7):1981-1984. PubMed ID: 28369424
    [Abstract] [Full Text] [Related]

  • 7. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH, Chen CC, Lee MF, Chuang YC, Tang HJ, Yu WL.
    J Microbiol Immunol Infect; 2017 Dec 01; 50(6):931-939. PubMed ID: 28716360
    [Abstract] [Full Text] [Related]

  • 8. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
    Tang HJ, Lai CC, Chen CC, Zhang CC, Weng TC, Chiu YH, Toh HS, Chiang SR, Yu WL, Ko WC, Chuang YC.
    J Microbiol Immunol Infect; 2019 Apr 01; 52(2):273-281. PubMed ID: 27133391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
    Evren E, Azap OK, Çolakoğlu Ş, Arslan H.
    Diagn Microbiol Infect Dis; 2013 Jul 01; 76(3):335-8. PubMed ID: 23726147
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
    Crémieux AC, Dinh A, Nordmann P, Mouton W, Tattevin P, Ghout I, Jayol A, Aimer O, Gatin L, Verdier MC, Saleh-Mghir A, Laurent F.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2666-2675. PubMed ID: 31263884
    [Abstract] [Full Text] [Related]

  • 13. Synergy Testing by E-Test and Microdilution Checkerboard for Fosfomycin Combined with Tigecycline against KPC-Producing Klebsiella pneumoniae.
    Huang L, Wang M, Sun L.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31850708
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
    Gaibani P, Lombardo D, Lewis RE, Mercuri M, Bonora S, Landini MP, Ambretti S.
    J Antimicrob Chemother; 2014 Jul 01; 69(7):1856-65. PubMed ID: 24648503
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
    Tängdén T, Hickman RA, Forsberg P, Lagerbäck P, Giske CG, Cars O.
    Antimicrob Agents Chemother; 2014 Jul 01; 58(3):1757-62. PubMed ID: 24395223
    [Abstract] [Full Text] [Related]

  • 16. In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development.
    Souli M, Galani I, Boukovalas S, Gourgoulis MG, Chryssouli Z, Kanellakopoulou K, Panagea T, Giamarellou H.
    Antimicrob Agents Chemother; 2011 May 01; 55(5):2395-7. PubMed ID: 21321144
    [Abstract] [Full Text] [Related]

  • 17. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA, Ashcraft DS.
    Diagn Microbiol Infect Dis; 2011 Aug 01; 70(4):561-4. PubMed ID: 21767715
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.
    Papadimitriou-Olivgeris M, Bartzavali C, Spyropoulou A, Lambropoulou A, Sioulas N, Vamvakopoulou S, Karpetas G, Spiliopoulou I, Vrettos T, Anastassiou ED, Fligou F, Christofidou M, Marangos M.
    Diagn Microbiol Infect Dis; 2018 Nov 01; 92(3):235-240. PubMed ID: 30076041
    [Abstract] [Full Text] [Related]

  • 19. In vitro interactions of combinations of colistin with meropenem, rifampicin and tigecycline in colistin-resistant, biofilm-forming Klebsiella pneumoniae.
    Müderris T, Dursun Manyaslı G, Kaya S, Gül Yurtsever S.
    Diagn Microbiol Infect Dis; 2024 Oct 01; 110(2):116408. PubMed ID: 39079190
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R.
    Pharmacotherapy; 2008 Mar 01; 28(3):295-300. PubMed ID: 18294108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.